300 Vials Per Minute: The Pace of Progress for Catalent

Posted: Updated:
A Catalent employee inspects a vial. A Catalent employee inspects a vial.

Just 18 months after entering Indiana’s life sciences landscape, Catalent says the “red hot” biologics sector is driving the company’s repeated large investments in Bloomington. Catalent, a contract development and manufacturing organization, does business with 41 of the top 50 biotechnology companies globally. As one of Catalent’s two nerve centers for biologics, the Bloomington site is growing at a breathtaking pace; Catalent has announced $114 million worth of investments in the operation during recent months, and executives believe there could be more.

“Our site in Bloomington may require even further investment in future years to keep up with ongoing demand,” says Bernie Clark, vice president of marketing and strategy for biologics and specialty drug delivery at Catalent.

The global company, based in New Jersey, generated $2.5 billion in annual revenue in fiscal 2018. Clark says biologics is one of the fastest growing markets in pharmaceuticals and drug development, and the Bloomington facility—which Catalent acquired from homegrown Cook Pharmica in 2017—focuses solely on this cutting-edge area of medicine.

Biologics—such as vaccines, gene therapy and tissues—demand state-of-the-art technology due to their highly sensitive and complex nature. Unlike conventional drugs with simpler structures that are produced by chemical reaction, biologics may be living organisms, such as cells and tissues.  

“[Biologics] are not your typical over-the-counter tablet; these are very advanced medicines, typically focused on difficult-to-treat diseases and illnesses, ranging from cancer to cardiovascular and infectious disease,” says Clark.  

Noting “there weren’t too many facilities quite like Bloomington” in the U.S., company leaders knew the high-tech operation would be up to the task when it acquired the location from Cook Pharmica.

“At Bloomington, in particular, we work on some of the most innovative molecules, starting with cell line development,” says Clark. “We help our customers grow products inside bioreactors at high volumes before taking the purified byproducts of those cells and filling them into liquid dose forms—sterile injectables, such as vials and syringes—and finally, packaging and labeling them for distribution to patients around the globe.”

Catalent recently announced it’s pumping $100 million into the plant to meet growing demand for biologics. The plans come on the heels of an earlier announcement to invest $14 million to ramp up packaging capabilities. A new high-speed line will fill 300 vials per minute, as well as a syringe/cartridge line that will operate at the same mind-boggling pace.

The increased volume is needed for the growing operation; in the 18 months since Catalent acquired the facility, it has expanded production from 12 commercial products to 20—a 66 percent increase.

 “More than capital, people are fundamental to making that growth a success,” says Clark. “We have dozens of job openings today, and we’ll be hiring hundreds in the coming years to ramp up our operations and deliver for our customers.”

Catalent believes Bloomington’s pocket of life sciences companies, plus the proximity of Indiana University and Indianapolis, will meet its appetite for workers. Additionally, the state’s talent and workforce development initiative Ascend Indiana is working with Catalent and a handful of higher education partners to launch a project that will expand the pool of line operators for the Bloomington facility.

“To fill the magnitude of positions we’ll have open in the coming years, it’s going to take employees of all skill levels and backgrounds, from packaging and operations to lab science, to quality and engineering—across the board,” says Clark.

Of the seven U.S. facilities that comprise its biologic division, Bloomington is one of only two getting a $100 million dose of capital—the perfect medicine, says Catalent, to support the boom in biologics.

Clark says several factors are contributing to the “red hot” nature of the biologics sector.
Clark says production at the Bloomington facility relies on high-tech bioreactors.
  • Perspectives

    • 3 Tips to Attract and Retain Employees in the Gig Economy

      The gig economy has been around ever since workers began looking for supplemental income, but, it has recently evolved with the introduction of technology. Companies emerging like Uber, Lyft and GrubHub, are changing the gig economy landscape of the workforce. The gig economy has attracted millennials and Gen Zers because of the flexibility and autonomy to work from anywhere, at any time.

    More

Subscribe

Name:
Company Name:
Email:
Confirm Email:
HTML
INside Edge
Morning Briefing
BigWigs & New Gigs
Life Sciences Indiana
Indiana Connections
INPower
Subscribe
Unsubscribe

Events



  • Most Popular Stories

    • (Industrial hemp photo courtesy of Purdue University)

      Hemp Processor Announces Expansion

      Indianapolis-based BDX Indiana has announced plans to bring more than 100 new jobs to central Indiana, with about a third of those going to a planned hemp extraction facility in Westfield. BDX extracts CBD oil from Indiana-grown hemp and is a sister company of Biodynamic Ventures, the largest hemp grower in Indiana. The city says the phase one build-out of the overall $50 million project is expected to begin this month with production to start in December. 

    • Butler Blue III is retiring next spring as the school's mascot. (photo courtesy Butler University)

      Butler Mascot Set to Retire

      One of the best-known ambassadors for Butler University is stepping down, all four legs of him, at the end of the current academic year. The university says their furry mascot, Butler Blue III, is ready to retire after nearly eight years of greeting visitors, students and staff. 

    • (photo courtesy of Indianapolis International Airport)

      Indy Airport Showcases New Retail Offerings

      Indianapolis International Airport is celebrating the opening of the first wave of new retail offerings. The new stores are part of the airport's multi-year Concessions Refresh initiative, which aims to bring a greater mix of nationally-known brands, such as FAO Schwarz and Vineyard Vines, with more local offerings, including Natalie's Candy Jar and Fountain Square Market. In all, nine new retail stores opened Tuesday morning. In an interview with Inside INdiana Business...

    • (image courtesy of Pixabay/VIN JD)

      Cyber Security Battalion to be Located in Indiana

      Indiana’s growing defense industry is further expanding into the digital battlefield. Governor Eric Holcomb has announced a National Guard cyber battalion will be located in the Hoosier state. The 127th Cyber Protection Battalion will be made up of nearly 100 soldiers focused on cybersecurity and cyber warfare. 

    • CEO of Knox County Development Corp. Steps Down

      The president and chief executive officer of the Knox County Development Corp. has resigned. Kent Utt had held the position for five years. Officials say Utt will continue to work with the corporation’s leadership to ensure a smooth transition going forward.